Indian doctors defend “unethical” anticancer drug trialBMJ 2001; 323 doi: http://dx.doi.org/10.1136/bmj.323.7308.299 (Published 11 August 2001) Cite this as: BMJ 2001;323:299
- Ganapati Mudur
- New Delhi
Indian doctors, accused of having breached ethics in trials of a candidate drug against cancer, have said that the study was done with the consent of patients, hospital ethics panels, and government officials.
India's health ministry and Johns Hopkins University in Baltimore, Maryland, are investigating charges that doctors breached ethics when they tested the drug, developed at Johns Hopkins, on Indian patients with oral cancer. Johns Hopkins University is already at the centre of concerns over its use of inhaled hexamethonium in trials of drugs for asthma (see story below).
The investigation …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial